272 related articles for article (PubMed ID: 29380155)
1. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
[TBL] [Abstract][Full Text] [Related]
2. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.
Vyas TK; Babbar AK; Sharma RK; Misra A
J Drug Target; 2005 Jun; 13(5):317-24. PubMed ID: 16199375
[TBL] [Abstract][Full Text] [Related]
3. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan.
Yu C; Gu P; Zhang W; Cai C; He H; Tang X
Drug Deliv; 2011 Nov; 18(8):578-85. PubMed ID: 21838542
[TBL] [Abstract][Full Text] [Related]
5. Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment.
Awadeen RH; Boughdady MF; Meshali MM
Int J Nanomedicine; 2020; 15():8553-8568. PubMed ID: 33173292
[TBL] [Abstract][Full Text] [Related]
6. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
Girotra P; Singh SK; Kumar G
Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
[TBL] [Abstract][Full Text] [Related]
7. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A
Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method.
Khezri FANZ; Lakshmi CSR; Bukka R; Nidhi M; Nargund SL
Int J Biol Macromol; 2020 Jan; 142():52-62. PubMed ID: 31593739
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan.
Kaur K; Kaur G
Biomed Res Int; 2013; 2013():958465. PubMed ID: 24175310
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of brain targeting and mucosal integrity of nasally administrated nanostructured carriers of a CNS active drug, clonazepam.
Abdel-Bar HM; Abdel-Reheem AY; Awad GA; Mortada ND
J Pharm Pharm Sci; 2013; 16(3):456-69. PubMed ID: 24021293
[TBL] [Abstract][Full Text] [Related]
11. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
Shelke S; Shahi S; Jalalpure S; Dhamecha D
J Liposome Res; 2016 Dec; 26(4):313-23. PubMed ID: 26758957
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug.
Alam MI; Baboota S; Ahuja A; Ali M; Ali J; Sahni JK; Bhatnagar A
Int J Pharm; 2014 Aug; 470(1-2):99-106. PubMed ID: 24810241
[TBL] [Abstract][Full Text] [Related]
13. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
Gadhave DG; Tagalpallewar AA; Kokare CR
AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
[TBL] [Abstract][Full Text] [Related]
14. Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy.
Jain R; Nabar S; Dandekar P; Patravale V
Pharm Res; 2010 Apr; 27(4):655-64. PubMed ID: 20151180
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
[TBL] [Abstract][Full Text] [Related]
16. Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery.
Rashed HM; Shamma RN; Basalious EB
Drug Deliv; 2016 Nov; 24(1):181-187. PubMed ID: 28156162
[TBL] [Abstract][Full Text] [Related]
17. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.
Abdou EM; Kandil SM; Miniawy HMFE
Int J Pharm; 2017 Aug; 529(1-2):667-677. PubMed ID: 28729175
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of zolmitriptan submicron emulsion for rapid and effective nasal absorption in beagle dogs.
Yu C; Gu P; Zhang W; Qi N; Cai C; He H; Tang X
Drug Dev Ind Pharm; 2011 Dec; 37(12):1509-16. PubMed ID: 21671836
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery.
Jha S; Mishra D
Pharm Nanotechnol; 2022; 10(2):113-124. PubMed ID: 35240970
[TBL] [Abstract][Full Text] [Related]
20. Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation.
Masjedi M; Azadi A; Heidari R; Mohammadi-Samani S
J Pharm Pharmacol; 2020 Oct; 72(10):1341-1351. PubMed ID: 32579251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
